Methanex
MEOH
60.41
-0.40
-0.66%
Methanex
US · MEOH
#2177 by market cap
Listed 1970
60.41
-0.40
-0.66%
Live - 5344 symbols - heartbeat 357s ago
· 2026-10-08 06:49
Pre-market
60.52
+0.18%
After-hours
60.41
0.00%
Overnight
60.46
+0.08%
- Market cap
- 4.67B
- P/E (TTM)i
- 63.59
- P/Bi
- 1.82
- EPSi
- 0.93
- Div yieldi
- 1.22%
- 52W posi
- 83%
Reader sentiment
Are you bullish or bearish on MEOH?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Weak
- Altman Z-Score is 1.76, below the 1.8 "distress zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year -3.51% YoY
Margins
- Gross margin
- 25.33%
- Operating margin
- 12.90%
- Net margin
- 2.23%
Key ratios & quality
- Enterprise valuei
- 7.11B
- Altman Z-Scorei
- 1.76
Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 4.48B | 3.28B | 2.65B | 4.41B | 4.31B | 3.72B | 3.72B | 3.59B |
| Gross profit | 1.34B | 779.84M | 615.94M | 1.08B | 865.09M | 655.40M | 710.42M | 909.09M |
| Selling & admin expenses | 182.52M | 184.17M | 246.78M | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 829.62M | 139.45M | -62.29M | 711.97M | 492.67M | 263.57M | 324.72M | 463.08M |
| Pretax profit | 811.48M | 120.84M | -187.43M | 666.34M | 582.15M | 285.61M | 280.09M | 203.24M |
| Tax | 153.49M | 4.47M | -62.11M | 110.43M | 119.86M | 1.49M | 29.84M | 58.45M |
| Net profit | 657.98M | 116.37M | -125.33M | 555.91M | 462.29M | 284.12M | 250.25M | 144.79M |
| Basic EPS | 7 | 1 | -2 | 6 | 5 | 3 | 2 | 1 |
| Diluted EPS | 6.92 | 1.01 | -2.06 | 6.13 | 4.86 | 2.57 | 2.39 | 0.93 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 896.47M | 796.51M | 927.44M | 968.81M | 973.72M | 1.40B |
| Gross profit | 315.83M | 215.64M | 179.34M | 198.29M | 203.24M | 638.01M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 209.72M | 113.40M | 68.47M | 71.48M | 83.36M | 517.47M |
| Pretax profit | 167.65M | 85.91M | 7.99M | -58.31M | 6.18M | 347.21M |
| Tax | 36.06M | 2.68M | 3.79M | 15.91M | 2.99M | 103.98M |
| Net profit | 131.59M | 83.23M | 4.19M | -74.22M | 3.20M | 243.23M |
| Basic EPS | 2 | 1 | 0 | -1 | 0 | 3 |
| Diluted EPS | 1.44 | 0.93 | -0.09 | -1.15 | -0.18 | 2.45 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.25B | 1.23B | 1.59B | 1.99B | 1.88B | 1.48B | 1.91B | 1.49B |
| Cash & ST investments | 256.08M | 416.76M | 833.84M | 932.07M | 857.75M | 458.02M | 891.91M | 425.33M |
| Inventory | 387.96M | 281.05M | 308.70M | 459.56M | 439.77M | 426.77M | 453.46M | 494.67M |
| Total assets | 4.61B | 5.20B | 5.70B | 6.09B | 6.63B | 6.43B | 6.60B | 7.28B |
| Total current liabilities | 1.05B | 648.25M | 765.39M | 963.22M | 942.62M | 1.30B | 729.62M | 721.74M |
| Short-term debt | 393.03M | 128.24M | 137.29M | 110.08M | 123.87M | 435.45M | 136.47M | 154.49M |
| Long-term debt | 1.07B | 1.73B | 2.32B | 2.15B | 2.14B | 1.83B | 2.40B | 2.71B |
| Total liabilities | 2,801,158,000.00 | 3,566,255,000.00 | 4,254,594,000.00 | 4,134,889,000.00 | 4,202,023,000.00 | 4,253,538,000.00 | 4,215,860,000.00 | 4,555,997,000.00 |
| Total equity | 1.81B | 1.63B | 1.44B | 1.95B | 2.43B | 2.17B | 2.38B | 2.73B |
| Retained earnings | 1.15B | 1.04B | 843.61M | 1.25B | 1.47B | 1.51B | 1.63B | 1.65B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 2.01B | 1.58B | 1.51B | 1.49B | 1.50B | 1.68B |
| Cash & ST investments | 1.09B | 485.38M | 413.38M | 425.33M | 379.02M | 382.91M |
| Inventory | 410.06M | 517.39M | 549.57M | 494.67M | 535.48M | 583.68M |
| Total assets | 6.66B | 7.75B | 7.53B | 7.28B | 7.21B | 7.18B |
| Total current liabilities | 635.95M | 740.18M | 722.52M | 721.74M | 764.56M | 808.43M |
| Short-term debt | 134.22M | 162.19M | 158.74M | 154.49M | 174.04M | 142.75M |
| Long-term debt | 2.40B | 2.91B | 2.79B | 2.71B | 2.65B | 2.39B |
| Total liabilities | 4,114,948,000.00 | 4,834,595,000.00 | 4,656,746,000.00 | 4,555,997,000.00 | 4,506,386,000.00 | 4,300,888,000.00 |
| Total equity | 2.54B | 2.92B | 2.87B | 2.73B | 2.70B | 2.88B |
| Retained earnings | 1.73B | 1.78B | 1.76B | 1.65B | 1.63B | 1.81B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 980.21M | 515.43M | 461.08M | 994.37M | 987.35M | 660.27M | 737.18M | 1.02B |
| Depreciation & amortization | 245.30M | 344.13M | 357.13M | 363.08M | 372.42M | 391.83M | 385.70M | 446.01M |
| Free cash flow | 735.73M | 191.57M | 119.27M | 748.93M | 409.97M | 211.82M | 563.11M | 916.57M |
| Dividends paid | -105.68M | -107.88M | -36.00M | -24.63M | -43.96M | -49.38M | -49.87M | -53.55M |
| Stock buybacks / issuance | -444.41M | -52.81M | 0 | -62.90M | -252.99M | -86.39M | -- | -- |
| Ending cash balance | 256.08M | 416.76M | 833.84M | 932.07M | 857.75M | 458.02M | 891.91M | 425.33M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 315.20M | 276.86M | 184.19M | 239.31M | 132.07M | 439.46M |
| Depreciation & amortization | 106.10M | 102.23M | 110.87M | 126.81M | 119.88M | 120.53M |
| Free cash flow | 267.89M | 246.19M | 177.33M | 225.15M | 109.65M | 424.16M |
| Dividends paid | -12.47M | -12.47M | -14.31M | -14.31M | -14.35M | -14.28M |
| Stock buybacks / issuance | -- | -- | -- | -- | -- | -- |
| Ending cash balance | 1.09B | 485.38M | 413.38M | 425.33M | 379.02M | 382.91M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 37.78 | 6.17 | -12.63 | 34.06 | 18.64 | 8.61 | 8.15 | 3.52 |
| ROA %i | 12.34 | 1.79 | -2.88 | 8.19 | 5.56 | 2.67 | 2.52 | 1.15 |
| ROIC %i | 21.50 | 6.00 | -1.15 | 13.69 | 9.02 | 4.98 | 5.28 | 3.87 |
| 5-year avg ROE %i | 19.06 | 15.01 | 10.20 | 17.16 | 16.81 | 10.97 | 11.37 | 14.60 |
| EBIT margin %i | 23.04 | 7.47 | -0.85 | 18.37 | 16.54 | 10.82 | 11.10 | 11.78 |
| FCF / sales %i | 18.71 | 5.83 | 4.50 | 16.96 | 9.51 | 5.69 | 15.14 | 25.54 |
| Current ratioi | 1.20 | 1.90 | 2.08 | 2.06 | 1.99 | 1.14 | 2.62 | 2.06 |
| Quick ratioi | 0.74 | 1.40 | 1.63 | 1.54 | 1.44 | 0.76 | 1.87 | 1.23 |
| Debt / assetsi | 35.97 | 47.87 | 54.17 | 47.22 | 45.57 | 46.90 | 49.01 | 48.17 |
| LT debt / equityi | 83.71 | 177.15 | 256.58 | 164.25 | 137.21 | 133.54 | 147.91 | 137.26 |
| Interest coveragei | 9.59 | 1.97 | -0.14 | 5.61 | 5.45 | 3.43 | 3.11 | 1.93 |
| Revenue CAGR (3Y) %i | 26.29 | 18.00 | -4.69 | -0.51 | 9.50 | 12.00 | -5.55 | -5.93 |
| Net income CAGR (3Y) %i | 41.55 | -- | -- | -5.36 | 59.16 | -- | -30.21 | -39.11 |
| FCF CAGR (3Y) %i | -- | 14.75 | -43.94 | 0.59 | 28.87 | 21.10 | -9.07 | 30.76 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 10.56 | 10.87 | 9.35 | 3.52 | -1.94 | 3.41 |
| ROA %i | 3.42 | 3.55 | 3.05 | 1.15 | -0.65 | 1.18 |
| ROIC %i | 6.55 | 6.83 | 7.35 | 3.87 | 1.34 | 3.71 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 14.36 | 16.00 | 15.07 | 11.78 | 7.26 | 12.42 |
| FCF / sales %i | 21.29 | 25.55 | 25.99 | 25.54 | 20.68 | 21.95 |
| Current ratioi | 3.17 | 2.13 | 2.09 | 2.06 | 1.96 | 2.07 |
| Quick ratioi | 2.33 | 1.31 | 1.18 | 1.23 | 1.16 | 1.24 |
| Debt / assetsi | 48.46 | 48.49 | 48.02 | 48.17 | 47.91 | 43.65 |
| LT debt / equityi | 137.70 | 137.05 | 134.47 | 137.26 | 136.21 | 116.55 |
| Interest coveragei | 3.41 | 3.19 | 2.53 | 1.93 | 1.19 | 2.34 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Single-engine
- Methanol revenue is the largest reported line at 96.13% of revenue, across 2 reported segments.
- The next-largest line, Ammonia and other revenue, is a distant second at 3.87% - a sharp slowdown here would have little to offset it.
Revenue breakdown most recent period
Business
Methanol revenue96.13%
Ammonia and other revenue3.87%
Region
Europe25.98%
United States19.72%
South America14.19%
China13.52%
South Korea12.40%
Other Asia9.41%
Canada4.78%
Quote time 2026-10-08 06:49:07 · For reference only, not investment advice and not tailored to your situation.